Search Results - "BLAZEK, Bohumir"

Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria by MEJSTRIKOVA, Ester, VOLEJNIKOVA, Jana, PROCHAZKOVA, Daniela, HAK, Jiri, ZEMANOVA, Zuzana, JAROSOVA, Marie, OLTOVA, Alexandra, SEDLACEK, Petr, SCHWARZ, Jiri, ZUNA, Jan, TRKA, Jan, STARY, Jan, FRONKOVA, Eva, HRUSAK, Ondrej, ZDRAHALOVA, Katerina, KALINA, Tomas, STERBA, Jaroslav, JABALI, Yahia, MIHAL, Vladimir, BLAZEK, Bohumir, CERNA, Zdena

“…Mixed phenotype acute leukemia (MPAL) represents a diagnostic and therapeutic dilemma. The European Group for the Immunological Classification of Leukemias…”
Get full text

Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis by VOLEJNIKOVA, Jana, MEJSTRIKOVA, Ester, HAK, Jiri, CERNA, Zdenka, HRUSAK, Ondrej, STARY, Jan, TRKA, Jan, FRONKOVA, Eva, VALOVA, Tatana, REZNICKOVA, Leona, HODONSKA, Ladislava, MIHAL, Vladimir, STERBA, Jaroslav, JABALI, Yahia, PROCHAZKOVA, Daniela, BLAZEK, Bohumir

“…Most minimal residual disease-directed treatment interventions in current treatment protocols for acute lymphoblastic leukemia are based on bone marrow…”
Get full text

Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens by Kotlín, Roman, Blažek, Bohumír, Suttnar, Jiří, Malý, Martin, Kvasnička, Jan, Dyr, Jan E

“…A 2-year-old asymptomatic boy and his relatives were investigated for a suspected fibrinogen mutation after coagulation tests revealed a decreased functional…”
Get full text

Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial by Kenet, Gili, Chambost, Hervé, Male, Christoph, Lambert, Thierry, Halimeh, Susan, Chernova, Tatiana, Mancuso, Maria Elisa, Curtin, Julie, Voigt, Christine, Li, Yanyan, Jacobs, Iris, Santagostino, Elena

“…A global phase 3 study evaluated the pharmacokinetics, efficacy and safety of a recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP)…”
Get more information

Inhibitors incidence rate in Czech previously untreated patients with haemophilia A has not increased since introduction of recombinant factor VIII treatment in 2003 by Blatny, Jan, Komrska, Vladimir, Blazek, Bohumir, Penka, Miroslav, Ovesna, Petra

“…Our objective was to assess the incidence of inhibitors development in Czech Republic since the introduction of recombinant factor VIII (rFVIII) and to look…”
Get full text

Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia by Spenerova, Michaela, Dzubak, Petr, Srovnal, Josef, Radova, Lenka, Burianova, Renata, Konecny, Petr, Salkova, Sona, Novak, Zbynek, Pospisilova, Dagmar, Stary, Jan, Blazek, Bohumir, Hak, Jiri, Votava, Tomas, Timr, Pavel, Kaiserova, Emilia, Bubanska, Eva, Mihal, Vladimir, Hajduch, Marian

“…Glucocorticoids, particularly prednisone/ prednisolone and dexamethasone, play a prominent role in the treatment of pediatric patients with acute lymphoblastic…”
Get full text

Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients by ELBL, Lubomir, HRSTKOVA, Hana, TOMASKOVA, Iva, BLAZEK, Bohumir, MICHALEK, Jaroslav

“…The authors conducted an 8-year prospective non-randomised study to determine whether dexrazoxane (ICRF-187) would reduce late anthracycline-induced…”
Get full text

Prognostic Impact of Peripheral Blood Involvement during Early Time Points of Childhood ALL Treatment by Volejnikova, Jana, Fronkova, Eva, Mejstrikova, Ester, Muzikova, Katerina, Reznickova, Leona, Pospisilova, Dagmar, Sterba, Jaroslav, Jabali, Yahia, Prochazkova, Daniela, Blazek, Bohumir, Hak, Jiri, Cerna, Zdenka, Stary, Jan, Trka, Jan

“…Minimal residual disease (MRD) testing performed on bone marrow (BM) samples has become a part of the risk group stratification procedure in several of the…”
Get full text

Human immunoglobulin (KIOVIG®/GAMMAGARD LIQUID®) for immunodeficiency and autoimmune diseases: an observational cohort study by Blažek, Bohumír, Misbah, Siraj A, Soler-Palacin, Pere, McCoy, Barbara, Leibl, Heinz, Engl, Werner, Empson, Victoria, Gelmont, David, Nikolov, Nikolai

“…To document the therapeutic efficacy and safety of Human Normal Immunoglobulin 10% Liquid (KIOVIG(®)/GAMMAGARD LIQUID(®) [IVIG 10%]) under clinical routine…”
Get full text

Development of treatment and clinical results in childhood acute myeloid leukemia in the Czech Republic by Sramkova, Lucie, Sterba, Jaroslav, Hrstkova, Hana, Mihal, Vladimir, Blazek, Bohumir, Timr, Pavel, Cerna, Zdena, Prochazkova, Daniela, Hak, Jiri, Sedlacek, Petr, Janotova, Iveta, Vodickova, Elena, Zemanova, Zuzana, Jarosova, Marie, Oltova, Alexandra, Zdrahalova, Katerina, Hrusak, Ondrej, Mejstrikova, Ester, Schwarz, Jiri, Zuna, Jan, Trka, Jan, Stary, Jan

“…Purpose Treatment of childhood acute myeloid leukemia (AML) was unified in the year 1993 according to acute myeloid leukemia-Berlin–Frankfurt–Munster (AML-BFM)…”
Get full text

Intravenous immunoglobulin as prophylaxis of chemotherapy-induced oral mucositis by Plevova, Pavlina, Blazek, Bohumir

Get full text

Evans' Syndrome in a Child with Diabetes Mellitus by Plevová, Pavlína, Cermáková, Radomíra, Lochmanová, Alexandra, Pták, Jan, Blazek, Bohumír, Starý, Jan

“…A patient suffering from infantile-onset insulin-dependent diabetes mellitus is reported in whom immune pancytopenia (Evans' syndrome) developed at the age of…”
Get full text

Treatment of Czech children with acute lymphoblastic leukemia: A report of the Czech working group for pediatric hematology by Starý, Jan, Gajdoš, Petr, Hrstková, Hana, Blažek, Bohumír, Slavík, Zdeněk, Mihál, Vladimír, Zahálka, František, Jabali, Yahia, Vávra, Vladimír, Kopečná, Lenka, Mydlil, Jan, Trka, Jan

Get full text

The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial by Zdráhalová, Kateřina, Štěrba, Jaroslav, Domanský, Jiří, Blažek, Bohumír, Ptoszková, Hana, Mihál, Vladimír, Novák, Zbyněk, Hak, Jiří, Procházková, Daniela, Černá, Zdena, Timr, Pavel, Jabali, Yahia, Sedláček, Petr, Smíšek, Petr, Zemanová, Zuzana, Jarošová, Marie, Houdková, Alena, Mejstříková, Ester, Hrušák, Ondřej, Zuna, Jan, Janotová, Iveta, Trka, Jan, Starý, Jan

“…Acute lymphoblastic leukemia (ALL) is the most frequent childhood malignancy. Treatment has been unified in the middle of 1980 in the Czech Republic. In…”
Get more information

Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells by Mihál, V, Hajdúch, M, Nosková, V, Feketová, G, Jess, K, Gojová, L, Kaspárek, I, Starý, J, Blazek, B, Pospísilová, D, Novák, Z

“…This study was designed to compare the antileukemic activity of prednisolone and dexamethasone in childhood acute lymphoblastic leukemia (ALL) under in vitro…”
Get more information